← Glossary

New Drug Application

NDA

FDA & Regulatory

A New Drug Application (NDA) is the formal request to the FDA to approve a small-molecule drug for marketing. Its acceptance sets the PDUFA review clock; biologics use the parallel Biologics License Application (BLA) instead.

Related terms

Biologics License ApplicationPDUFA DateComplete Response LetterSupplemental New Drug Application

Track New Drug Application across 1,000+ biotechs

BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.

Start Free